ACYCLOVIR INHIBITION OF EPSTEIN-BARR VIRUS-REPLICATION
ACYCLOVIR INHIBITION OF EPSTEIN-BARR VIRUS-REPLICATION
复制标题
DOI:
10.1073/pnas.77.9.5163
复制
发表时间:
1980-01-01
期刊:
影响因子:
--
通讯作者:
PAGANO, JS
中科院分区:
文献类型:
--
作者:
DATTA, AK;COLBY, BM;PAGANO, JS
Acyclovir [9-(2-hydroxyethoxymethyl)guanine] triphosphate inhibits Epstein-Barr virus (EBV)-associated DNA polymerase (DNA nucleotidyltransferase; EC 2.7.7.7) to a greater extent than it inhibits host .alpha. and .beta. DNA polymerases. The affinity of the compound for viral polymerase is 100-fold higher than for .alpha.-polymerase. The extent of inhibition is dependent upon the base composition of the template-primer. The inhibition is prevented by increasing concentrations of deoxyguanosine triphosphate. The EBV-associated DNA polymerase reaction in the presence of the inhibitor, although depressed, proceeds at a linear rate over a long period of time. In contrast, the reaction of Escherichia coli DNA polymerase I in the presence of 2'',3''-dideoxythymidine 5''-triphosphate, a DNA chain terminator, levels off after initial linearity. Preincubation of acyclovir triphosphate with DNA and enzyme does not increase its inhibitory activity. The virus-producing cell line P3HR-1 [human Burkitt''s lymphoma] consistently shows reduced viral genome numbers and viral capsid antigen on prolonged exposure to acyclovir. The number of EBV genomes returns to the control level when the cells are grown in drug-free medium. The results suggest that a competitive mechanism is the major mode of acyclovir inhibition of EBV replication.